Neurology

Studies by American researchers suggest that the erectile dysfunction drug sildenafil could decrease a person’s risk for Alzheimer’s disease.

Dr. Dwight Moulin and Dr. Anuj Bhatia walk through managing patient expectations and effective titration.

Ponesimod is the fourth oral sphingosine 1-phosphate receptor modulator to be marketed in Canada.

Dorothy Shephard told a news conference in Fredericton that an epidemiological study has found no known food, behaviour or environmental exposure that could have caused the symptoms of a mystery brain syndrome.

Dizziness and vertigo are among the most common complaints primary care physicians see in their offices or hear about during their virtual visits. What do you know about dizziness and vertigo?

Study suggests minimal risk of relapse when Pfizer-BioNTech mRNA COVID-19 vaccine is given to patients with a history of GBS.

A pharmacist at North York General Hospital helps older patients with Parkinson’s disease navigate symptoms and adverse events, one call at a time.